SKI Market

Indian Indices

Nifty

26,202.95 -12.60
(-0.05%)

Sensex

85,706.67 -13.71
( -0.02%)

Bank Nifty

59,752.70 15.40
( 0.03%)

Nifty IT

37,405.50 -40.80
( -0.11%)

Global Indices

Nasdaq

47,737.43 289.30
(0.61%)

Dow Jones

6,869.48 35.87
(0.52%)

Hang Seng

50,220.95 53.85
(0.11%)

Nikkei 225

9,721.02 27.09
(0.28%)

Forex

USD-INR

89.30 0.10
(0.11%)

EUR-INR

103.54 0.22
(0.21%)

GBP-INR

118.23 0.49
(0.41%)

JPY-INR

0.57 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

369.1611632

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

35.18

71084.31

EPS(TTM)

Face Value()

Div & Yield %

34.79

Back

Hikal receives revision in credit ratings from ICRA

Nov 25,2025

Hikal has received revision in credit ratings from ICRA as under:

Long term rating - ICRA A; Stable (revised from ICRA A+; Stable)
Short term rating - ICRA A2+ (revised from ICRA A1)

26,202.95 -12.60 (-0.05%)

85,706.67 -13.71 ( -0.02%)

59,752.70 15.40 ( 0.03%)

37,405.50 -40.80 ( -0.11%)

47,737.43 289.30 (0.61%)

6,869.48 35.87 (0.52%)

50,220.95 53.85 (0.11%)

9,721.02 27.09 (0.28%)

89.30 0.10 (0.11%)

103.54 0.22 (0.21%)

118.23 0.49 (0.41%)

0.57 0.00 (0.17%)